% Expired Patents = 100.0

Forward Citations = 1

Loading Chart...

2 inventors (with patents filed for the assignee):

John Daniel Dobak, Iii (7 out of 115 patents)

Kenneth Walter Locke (3 out of 19 patents)

7 patents: Sort by Forward Citations

1. 9707192 - Lipolytic methods (2017-07-18),

2. 9597531 - Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging (2017-03-21),

3. 9452147 - Lipolytic methods (2016-09-27),

4. 9452132 - Methods for administration and formulations for the treatment of regional adipose tissue (2016-09-27),

5. 9370498 - Methods of using lipolytic formulations for regional adipose tissue treatment (2016-06-21),

6. 9198885 - Lipolytic methods for regional adiposity comprising salmeterol or formoterol (2015-12-01),

7. 9132084 - Methods for administration and formulations for the treatment of regional adipose tissue (2015-09-15),

Company Overview

Neothetics, Inc. is a biopharmaceutical company focused on developing and commercializing aesthetic and therapeutic products. The company's lead product candidate is LIPO-202, a targeted injectable drug designed to reduce localized fat deposits. Neothetics is dedicated to bringing innovative solutions to patients seeking aesthetic improvement and medical treatments.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#704 in San Diego, CA

#9,508 in California

#39,929 in US

San Diego, CA, United States of America

Neothetics, Inc.

Forward Citations = 1

2 inventors:

John Daniel Dobak, Iii (7 out of 115 patents)

Kenneth Walter Locke (3 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neothetics, Inc.. Retrieved from https://idiyas.com/company/neothetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]